RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Clinical trial NCT04252430 · TERMINATED

Trial details

NCT number: NCT04252430
Sponsor: MedDay Pharmaceuticals SA
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Impaired Renal Function

Start date: 2019-10-09
Primary completion: 2020-03-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.